Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Michelson

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|October 1, 1991
Topically active carbonic anhydrase inhibitors. 4. [(Hydroxyalkyl)sulfonyl]benzene and [(hydroxyalkyl)sulfonyl]thiophenesulfonamidesK L Shepard, S L Graham, R J Hudcosky, et al.
Journal of Medicinal Chemistry|June 1, 1991
New isomeric classes of topically active ocular hypotensive carbonic anhydrase inhibitors: 5-substituted thieno[2,3-b]thiophene-2-sulfonamides and 5-substituted thieno[3,2-b]thiophene-2-sulfonamidesJ D Prugh, G D Hartman, P J Mallorga, et al.
Journal of Medicinal Chemistry|May 1, 1983
Inhibitors of glycolic acid oxidase. 4-Substituted 3-hydroxy-1H-pyrrole-2,5-dione derivativesC S Rooney, W C Randall, K B Streeter, et al.
Journal of Medicinal Chemistry|February 7, 2003
Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cellsLinghang Zhuang, John S Wai, Mark W Embrey, et al.
Journal of Medicinal Chemistry|June 17, 1998
Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridinesI M Bell, J M Erb, R M Freidinger, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
Nonpeptide oxytocin antagonists: analogs of L-371,257 with improved potencyP D Williams, M G Bock, B E Evans, et al.
Journal of Medicinal Chemistry|September 9, 2000
Identification of MK-944a: a second clinical candidate from the hydroxylaminepentanamide isostere series of HIV protease inhibitorsB D Dorsey, C McDonough, S L McDaniel, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Orally efficacious NR2B-selective NMDA receptor antagonistsChristopher F Claiborne, John A McCauley, Brian E Libby, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|October 1, 1991
Topically active carbonic anhydrase inhibitors. 4. [(Hydroxyalkyl)sulfonyl]benzene and [(hydroxyalkyl)sulfonyl]thiophenesulfonamidesK L Shepard, S L Graham, R J Hudcosky, et al.
Journal of Medicinal Chemistry|June 1, 1991
New isomeric classes of topically active ocular hypotensive carbonic anhydrase inhibitors: 5-substituted thieno[2,3-b]thiophene-2-sulfonamides and 5-substituted thieno[3,2-b]thiophene-2-sulfonamidesJ D Prugh, G D Hartman, P J Mallorga, et al.
Journal of Medicinal Chemistry|May 1, 1983
Inhibitors of glycolic acid oxidase. 4-Substituted 3-hydroxy-1H-pyrrole-2,5-dione derivativesC S Rooney, W C Randall, K B Streeter, et al.
Journal of Medicinal Chemistry|February 7, 2003
Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cellsLinghang Zhuang, John S Wai, Mark W Embrey, et al.
Journal of Medicinal Chemistry|June 17, 1998
Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridinesI M Bell, J M Erb, R M Freidinger, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
Nonpeptide oxytocin antagonists: analogs of L-371,257 with improved potencyP D Williams, M G Bock, B E Evans, et al.
Journal of Medicinal Chemistry|September 9, 2000
Identification of MK-944a: a second clinical candidate from the hydroxylaminepentanamide isostere series of HIV protease inhibitorsB D Dorsey, C McDonough, S L McDaniel, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Orally efficacious NR2B-selective NMDA receptor antagonistsChristopher F Claiborne, John A McCauley, Brian E Libby, et al.
Pageof 3